Lurasidone added to antidepressants for major depression
Part of Mental health clinical trials.
This study tests whether adding lurasidone to your current antidepressant can help improve depression symptoms. It is for adults who have not gotten enough relief from their current antidepressant alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 64 years old
- You have a diagnosis of major depressive disorder
- Your current episode of depression has lasted at least 8 weeks
- You have tried an antidepressant but it did not work well enough (less than 50% improvement)
- You are currently taking at least one allowed antidepressant at a minimum effective dose for at least 6 weeks
- You are willing to stay on the same antidepressant for the entire study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication for adults with major depressive disorder who are currently taking an antidepressant but still have symptoms. It aims to see if adding this new drug can improve mood better than a placebo.
This trial tests if adding a new medicine called milsaperidone can help people with major depression who haven't gotten enough relief from their current antidepressant. It aims to see if the combination works better than the antidepressant alone.
This study tests whether adding lumateperone to an antidepressant helps adults with major depressive disorder (MDD) who haven’t improved enough after trying at least two different antidepressants. It may help reduce depressive symptoms more than antidepressants alone.
This study uses a special brain scan to learn how oxygen use in the brain relates to bipolar depression. It may help future treatments, and you will receive lurasidone (a medication) as part of the study.
This study tests a new medication (lumateperone) versus a placebo to see if it helps reduce symptoms of major depressive disorder. It is for people with moderate to severe depression who may be looking for a new treatment option.
This trial tests whether adding the study drug OSU6162 to your current antidepressant can help when standard medications haven't worked well enough. It aims to reduce depression symptoms over several weeks.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.